Skip to main content
Erschienen in:

01.12.2023 | Cardiology/CT Surgery (K Gist, Section Editor)

Ethical Challenges at the Frontiers of Medical Care for Children with Congenital Heart Disease in the U.S

verfasst von: Mithya Lewis-Newby, MD, MPH, Emily R. Berkman, MD, MA, Douglas S. Diekema, MD, MPH, Aarti H. Bhat, MD, Jonna D. Clark, MD, MA

Erschienen in: Current Treatment Options in Pediatrics | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purposeof review

The past 8 decades have seen tremendous medical and technological advancements in the care of children with congenital heart disease (CHD). As with all medical care, there are boundaries of established practices, and at the frontiers of innovation we often encounter ethical challenges. This paper reviews the current ethical challenges that arise in the medical care of children with CHD.

Recent findings

Ethical challenges are present at the individual, community, population, and system levels. This paper reviews three main categories of ethical challenges: (1) challenges of equity, including those based on social determinants of health, genetic differences, neurologic differences, and the impact on allocation of scarce resources; (2) challenges of decision-making, including team decision-making, shared decision-making, limits of parental authority, requests for life-prolonging therapies, and end-of-life decisions; and (3) challenges to the healthcare system, including costs, resource utilization, economic and research competition, and healthcare worker psychological distress.

Summary

There will always be ethical challenges at the frontiers of our medical capabilities that have no easy solutions. Recognizing and acknowledging these ethical tensions is an important first step to overcome these challenges. Prioritizing healthcare equity, collaboration, transparency, and advocacy will help guide ethically sound decisions for the well-being of patients, families, healthcare providers, and the healthcare system as we continue to push the boundaries of what is possible.
Literatur
1.•
Zurück zum Zitat Chowdhury D, Johnson JN, Baker-Smith CM, Jaquiss RDB, Mahendran AK, Curren V, Bhat A, Patel A, Marshall AC, Fuller S, Marino BS, Fink CM, Lopez KN, Frank LH, Ather M, Torentinos N, Kranz O, Thorne 1V, Davies RR, Berger S, Snyder C, Saidi A, Shaffer K. Health care policy and Congenital heart disease: 2020 focus on our 2030 future. J Am Heart Assoc 2021:10(20):e020605. https://doi.org/10.1161/JAHA.120.020605. This consensus statement identifies public health barriers to optimum patient outcomes in the care of children with congenital heart disease. The article highlights challenges for patient populations, healthcare delivery, and the healthcare workforce and makes recommendations for policy and advocacy efforts to address these barriers. Chowdhury D, Johnson JN, Baker-Smith CM, Jaquiss RDB, Mahendran AK, Curren V, Bhat A, Patel A, Marshall AC, Fuller S, Marino BS, Fink CM, Lopez KN, Frank LH, Ather M, Torentinos N, Kranz O, Thorne 1V, Davies RR, Berger S, Snyder C, Saidi A, Shaffer K. Health care policy and Congenital heart disease: 2020 focus on our 2030 future. J Am Heart Assoc 2021:10(20):e020605. https://​doi.​org/​10.​1161/​JAHA.​120.​020605. This consensus statement identifies public health barriers to optimum patient outcomes in the care of children with congenital heart disease. The article highlights challenges for patient populations, healthcare delivery, and the healthcare workforce and makes recommendations for policy and advocacy efforts to address these barriers.
2.•
Zurück zum Zitat Lopez KN, Baker-Smith C, Flores G, Gurvitz M, Karamlou T, Nunez Gallegos F, Pasquali S, Patel A, Peterson JK, Salemi JL, Yancy C, Peyvandi S. American Heart Association Congenital Cardiac Defects Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Epidemiology and Prevention; and Council on Lifestyle and Cardiometabolic Health. Addressing social determinants of health and mitigating health disparities across the lifespan in congenital heart disease: a scientific statement from the American Heart Association. J Am Heart Assoc. 2022;11(8):e025358. https://doi.org/10.1161/JAHA.122.025358. This AHA scientific statement outlines current disparities in outcomes for children with congenital heart disease and identifies a multitude of systemic factors that contribute to healthcare inequities. The article proposes strategies for reducing disparities as well as future research needs.CrossRefPubMedPubMedCentral Lopez KN, Baker-Smith C, Flores G, Gurvitz M, Karamlou T, Nunez Gallegos F, Pasquali S, Patel A, Peterson JK, Salemi JL, Yancy C, Peyvandi S. American Heart Association Congenital Cardiac Defects Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Epidemiology and Prevention; and Council on Lifestyle and Cardiometabolic Health. Addressing social determinants of health and mitigating health disparities across the lifespan in congenital heart disease: a scientific statement from the American Heart Association. J Am Heart Assoc. 2022;11(8):e025358. https://​doi.​org/​10.​1161/​JAHA.​122.​025358. This AHA scientific statement outlines current disparities in outcomes for children with congenital heart disease and identifies a multitude of systemic factors that contribute to healthcare inequities. The article proposes strategies for reducing disparities as well as future research needs.CrossRefPubMedPubMedCentral
3.•
Zurück zum Zitat Karamlou T, Hawke JL, Zafar F, Kafle M, Tweddell JS, Najm HK, Frebis JR, Bryant JG. Widening our focus: characterizing socioeconomic and racial disparities in congenital heart disease. Ann thorac surg. 2022;113(1):157–65. https://doi.org/10.1016/j.athoracsur.2021.04.008. This study examines disparities in outcomes of children with congenital heart disease (CHD) based on socioeconomic and racial (SER) differences by querying the Pediatric Health Information System (PHIS) database. More than 166,000 admissions for CHD from 52 hospitals were identified and outcome disparities were identified based on SER differences, particularly for children with complex CHD.CrossRefPubMed Karamlou T, Hawke JL, Zafar F, Kafle M, Tweddell JS, Najm HK, Frebis JR, Bryant JG. Widening our focus: characterizing socioeconomic and racial disparities in congenital heart disease. Ann thorac surg. 2022;113(1):157–65. https://​doi.​org/​10.​1016/​j.​athoracsur.​2021.​04.​008. This study examines disparities in outcomes of children with congenital heart disease (CHD) based on socioeconomic and racial (SER) differences by querying the Pediatric Health Information System (PHIS) database. More than 166,000 admissions for CHD from 52 hospitals were identified and outcome disparities were identified based on SER differences, particularly for children with complex CHD.CrossRefPubMed
5.••
Zurück zum Zitat Godown J, Fountain D, Bansal N, Ameduri R, Anderson S, Beasley G, Burstein D, Knecht K, Molina K, Pye S, Richmond M, Spinner JA, Watanabe J, West S, Reinhardt Z, Scheel J, Urschel S, Villa C, Hollander SA. Heart transplantation in children with down syndrome. J Am Heart Assoc. 2022;11(10):e024883. https://doi.org/10.1161/JAHA.121.024883. This retrospective case series investigates outcomes of children with trisomy 21 who received heart transplants between 1992 and 2020. Waitlist and transplant outcomes were found to be comparable to the general population of children receiving heart transplant. The authors suggest that trisomy 21 alone should not be considered an absolute contraindication to pediatric heart transplant.CrossRefPubMedPubMedCentral Godown J, Fountain D, Bansal N, Ameduri R, Anderson S, Beasley G, Burstein D, Knecht K, Molina K, Pye S, Richmond M, Spinner JA, Watanabe J, West S, Reinhardt Z, Scheel J, Urschel S, Villa C, Hollander SA. Heart transplantation in children with down syndrome. J Am Heart Assoc. 2022;11(10):e024883. https://​doi.​org/​10.​1161/​JAHA.​121.​024883. This retrospective case series investigates outcomes of children with trisomy 21 who received heart transplants between 1992 and 2020. Waitlist and transplant outcomes were found to be comparable to the general population of children receiving heart transplant. The authors suggest that trisomy 21 alone should not be considered an absolute contraindication to pediatric heart transplant.CrossRefPubMedPubMedCentral
7.••
Zurück zum Zitat Madrigal VN, Feltman DM, Leuthner SR, Kirsch R, Hamilton R, Dokken D, Needle J, Boss R, Lelkes E, Carter B, Macias E, Bhombal S. Bioethics for neonatal cardiac care. Pediatrics. 2022;150:e2022056415N. https://doi.org/10.1542/peds.2022-056415N. This AAP Supplement article identifies ethical issues that arise in the care of neonates with congenital heart disease. This article outlines ethical challenges and makes recommendations in the categories of fetal care, shared decision-making, genetic diagnoses, research, end-of-life care, healthcare equity, and outcomes reporting.CrossRefPubMed Madrigal VN, Feltman DM, Leuthner SR, Kirsch R, Hamilton R, Dokken D, Needle J, Boss R, Lelkes E, Carter B, Macias E, Bhombal S. Bioethics for neonatal cardiac care. Pediatrics. 2022;150:e2022056415N. https://​doi.​org/​10.​1542/​peds.​2022-056415N. This AAP Supplement article identifies ethical issues that arise in the care of neonates with congenital heart disease. This article outlines ethical challenges and makes recommendations in the categories of fetal care, shared decision-making, genetic diagnoses, research, end-of-life care, healthcare equity, and outcomes reporting.CrossRefPubMed
11.
Zurück zum Zitat Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT. American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126(9):1143–72. https://doi.org/10.1161/CIR.0b013e318265ee8a.CrossRefPubMed Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT. American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126(9):1143–72. https://​doi.​org/​10.​1161/​CIR.​0b013e318265ee8a​.CrossRefPubMed
13.••
Zurück zum Zitat Amdani S, Bhimani SA, Boyle G, Liu W, Worley S, Saarel E, Hsich E. Racial and ethnic disparities persist in the current era of pediatric heart transplantation. J Card Fail. 2021;27(9):957–64. https://doi.org/10.1016/j.cardfail.2021.05.027. This study investigates pediatric cardiac transplant waitlist and post-transplant disparities by race and ethnicity using the Scientific Registry of Transplant recipients database from 2011 to 2019. The authors identified increased waitlist mortality and increased post-transplant rejection episodes for African-American children.CrossRefPubMedPubMedCentral Amdani S, Bhimani SA, Boyle G, Liu W, Worley S, Saarel E, Hsich E. Racial and ethnic disparities persist in the current era of pediatric heart transplantation. J Card Fail. 2021;27(9):957–64. https://​doi.​org/​10.​1016/​j.​cardfail.​2021.​05.​027. This study investigates pediatric cardiac transplant waitlist and post-transplant disparities by race and ethnicity using the Scientific Registry of Transplant recipients database from 2011 to 2019. The authors identified increased waitlist mortality and increased post-transplant rejection episodes for African-American children.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Bosslet GT, Pope TM, Rubenfeld GD, Lo B, Truog RD, Rushton CH, Curtis JR, Ford DW, Osborne M, Misak C, Au DH, Azoulay E, Brody B, Fahy BG, Hall JB, Kesecioglu J, Kon AA, Lindell KO, White DB. An Official ATS/AACN/ACCP/ESICM/SCCM Policy statement: responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med. 2015;191(11):1318–30. https://doi.org/10.1164/rccm.201505-0924ST.CrossRefPubMed Bosslet GT, Pope TM, Rubenfeld GD, Lo B, Truog RD, Rushton CH, Curtis JR, Ford DW, Osborne M, Misak C, Au DH, Azoulay E, Brody B, Fahy BG, Hall JB, Kesecioglu J, Kon AA, Lindell KO, White DB. An Official ATS/AACN/ACCP/ESICM/SCCM Policy statement: responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med. 2015;191(11):1318–30. https://​doi.​org/​10.​1164/​rccm.​201505-0924ST.CrossRefPubMed
Metadaten
Titel
Ethical Challenges at the Frontiers of Medical Care for Children with Congenital Heart Disease in the U.S
verfasst von
Mithya Lewis-Newby, MD, MPH
Emily R. Berkman, MD, MA
Douglas S. Diekema, MD, MPH
Aarti H. Bhat, MD
Jonna D. Clark, MD, MA
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Current Treatment Options in Pediatrics / Ausgabe 4/2023
Elektronische ISSN: 2198-6088
DOI
https://doi.org/10.1007/s40746-023-00275-0

Weitere Artikel der Ausgabe 4/2023

Updates in the Approach to Pediatric HIV Care and Prevention

  • Pediatric Infectious Disease (M Mitchell and F Zhu, Section Editors)

The Advent of Spatial Omics in Congenital Heart Disease

  • Cardiology/CT Surgery (K Gist, Section Editor)

Kidney Manifestations of Rheumatological Diseases in Children

  • Open Access
  • Pediatric Nephrology (BP Dixon and E Nehus, Section Editors)

Nutrition Advice for the Pediatrician’s Office for Common Kidney Conditions

  • Pediatric Nephrology (BP Dixon and E Nehus, Section Editors)

Device Innovations in Pediatric Heart Failure

  • Cardiology/CT Surgery (K Gist, Section Editor)

Non-invasive Cardiac Output Monitoring in Congenital Heart Disease

  • Open Access
  • Cardiology/CT Surgery (K Gist, Section Editor)

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Pädiatrie

Weniger Bargeld, weniger Erstickungsnotfälle?

Dadurch, dass immer seltener mit Bargeld gezahlt wird, könnte die Rate an Erstickungsnotfällen bei Kindern zurückgehen. Dieser Hypothese ist ein britisches Forschungsteam in Klinikdaten aus den letzten zweieinhalb Jahrzehnten nachgegangen.

Pneumonie ausschließen: Auf das Röntgenbild ist offenbar Verlass

Das Thoraxröntgen ist gemäß Daten aus den USA eine zuverlässige Methode, um bei Kindern in der Notaufnahme rasch eine Lungenentzündung auszuschließen. Zur Vorsicht rät das Ärzteteam jedoch bei bestimmten klinischen Symptomen.

Kawasaki-Syndrom: Kein ASS mehr in der Akutphase?

Um Kinder mit Kawasaki-Syndrom vor entzündlich bedingten Veränderungen der Koronarien zu bewahren, werden sie in der Akutphase mit intravenösen Immunglobulinen und hochdosierter Acetylsalicylsäure (ASS) behandelt. Neuesten Daten zufolge könnte womöglich auf ASS verzichtet werden.

Neurologische Entwicklung von Kindern: Welchen Einfluss hat Stillen?

Stillen bringt zahlreiche gesundheitliche Vorteile mit sich. Ob dazu auch ein niedrigeres Risiko für Entwicklungsverzögerungen und -störungen gehört, hat nun eine israelische Studie untersucht.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.